Efficient enantioselective hydrolysis of D,L-phenylglycine methyl ester catalyzed by immobilized Candida antarctica lipase B in ionic liquid containing systems.
Immobilized Candida antarctica lipase B (Novozym 435)-catalyzed enantioselective hydrolysis of D,L-phenylglycine methyl ester to enatiopure D-phenylglycine was successfully conducted in the systems with ionic liquids (ILs). Novozym 435 exhibited excellent activity and enantioselectivity in the system containing the IL BMIMxBF(4) compared to several typical organic solvents tested. It has been found that the cations and, particularly, the anions of ILs have a significant effect on the reaction, and the IL BMIMxBF(4), which shows to be the most suitable for the reaction, gave the highest initial rate and enantioselectivity among various ILs examined. The reaction became much less active and enantioselective in the systems with BMIMxHSO(4). Also, it was noticed that the enzymatic hydrolysis was strongly dependent on BMIMxBF(4) content in the co-solvent systems and the favorable content of the IL was 20% (v/v). Of the assayed four co-solvents and phosphate buffer, the lowest apparent K(m) and activation energy, and the highest V(max) of the reaction were achieved using 20% (v/v) BMIMxBF(4) co-solvent with phosphate buffer. Additionally, various influential variables were investigated. The optimum pH, substrate concentration, reaction temperature and shaking rate were 8.0, 80mM, 25-30 degrees Celsius and 150rpm, respectively, under which the initial rate, the residual substrate e.e. and the enantioselectivity were 2.46mM/min, 93.8% (at substrate conversion of 53.0%) and 38, respectively. When the hydrolysis was performed under reduced pressure, the initial rate (2.64mM/min) and the enantioselectivity (E=43) were boosted.
College of Biological Sciences & Biotechnology, South China University of Technology, Guangzhou 510640, PR China.
Wen-Yong
WY
Lou
Min-Hua
MH
Zong
Yu-Ying
YY
Liu
Ju-Fang
JF
Wang
D001881:Borates / Q000737:chemistry / Q000494:pharmacology; D004795:Enzyme Stability / Q000187:drug effects; D004800:Enzymes, Immobilized / Q000737:chemistry / Q000378:metabolism*; D005656:Fungal Proteins; D005998:Glycine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis / Q000187:drug effects; D007093:Imidazoles / Q000737:chemistry / Q000494:pharmacology; D007477:Ions / Q000737:chemistry* / Q000494:pharmacology; D008049:Lipase / Q000737:chemistry / Q000378:metabolism*; D011312:Pressure; D012997:Solvents / Q000737:chemistry / Q000494:pharmacology; D013237:Stereoisomerism; D013696:Temperature; D014867:Water / Q000737:chemistry
C419324:1-butyl-3-methylimidazolium tetrafluoroborate; D001881:Borates; D004800:Enzymes, Immobilized; D005656:Fungal Proteins; D007093:Imidazoles; D007477:Ions; D012997:Solvents; D014867:Water; C033393:methyl phenylglycine; C093667:Novozyme 435; D008049:Lipase; C431349:lipase B, Candida antarctica; D005998:Glycine